Introduction of an Albumin-to-Creatinine Ratio Point-of-Care Device: Analytic, Clinical, and Cost-effectiveness Aspects

Plastic Surgical Nursing

Volumn 2, Issue 2, 2003, Pages 89-95

  Davidson, Elaine M ^a   Croal, Bernard L ^a,b  

^a NHS GRAMPIAN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Blood gas; Cardiac markers; Coagulation

Indexed keywords

EID: 34047180477     PISSN: 07415206     EISSN: 15501841     Source Type: Journal    
DOI: 10.1097/00134384-200306000-00003     Document Type: Article

References (15)

1. Gilbert R, Kelly D. Nephropathy in type 2 diabetes: current therapeutic strategies. Nephrology 2001; 6:266-269.
2. Rose B, McCulloch D, Bakris G. Microalbuminuria in Diabetic Nephropathy and as a Risk Factor for Cardiovascular Disease. [UpToDate.com Web site] January 18, 2002. Available at http://www.uptodate.com. Accessed March 1, 2002.
3. Gosling P. Microalbuminuria: a marker of systemic disease. Br J Hosp Med 1995; 54:285-290.
4. Sacks D, Bruns D, Goldstein D, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002; 48:436-472.
5. Scottish Intercollegiate Guidelines Network. Management of Diabetes. [SIGN Web site]. November 2001. Available at http://www.sign.ac.uk. Accessed June 28, 2002.
6. The Diabetes Control and Complications Trial Research Group. The effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int 1995; 4:1705-1720.
7. Kirby M. Screening for microalbuminuria. Br J Diabetes Vasc Dis 2002; 2:106-109.
8. Tayside Regional Diabetes Network. Diabetic Audit and Research Tayside Scotland (DARTS) Annual Report 2001. [DARTS Web site]. Available at http://www.diabetes-healthnet.ac.uk/report01/indicate.htm. Accessed on March 15, 2002.
9. Kost G, Ehrmeyer S, Chernow B, et al. The laboratory-clinical interface: point-of-care testing. Chest 1999; 115:1140-1154.
10. Crook M. Near patient testing and pathology in the new millennium. J Clin Pathol 2000; 53:27-30.
11. Price C. Point of care testing. BMJ 2001; 322:1285-1288.
12. Grieve R, Beech R, Vincent J, et al. Near patient testing in diabetes clinics: appraising the costs and outcomes. Health Technol Assess 1999; 3:1-86.
13. Delaney B, Hyde C, McManus R, et al. Systematic review of near patient test evaluations in primary care. BMJ 1999; 319:824-827.
14. Price C, Hicks J. Point of care testing in the management of diabetes mellitus. In: Price C, Hicks J, eds. Point of Care Testing. London: AACC Press; 1999;319-335.
15. Croal B, Mutch W, Clark B, et al. The clinical application of a urine albumin:creatinine ratio point-of-care device. Clin Chim Acta 2001; 307:15-21.